Tarang Manchanda

Tarang Manchanda is a seasoned professional in the pharmaceutical industry, with a robust background in medical strategy and clinical research. Currently serving as Franchise Head and Squad Lead for Rare and Gene Therapy at Roche, responsibilities include overseeing initiatives in spinal muscular atrophy, Duchenne muscular dystrophy, and hemophilia. Previous roles encompass Director of Medical Strategy with a focus on immunology, ophthalmology, and rare diseases, as well as leading medical planning and launch excellence. Tarang's experience at Wyeth Pharmaceuticals as an Area Account Manager and at Bristol-Myers Squibb as a Clinical Research Associate further solidifies a comprehensive understanding of both sales and clinical operations. Educational qualifications include a Master of Science in Pharmacology and Toxicology from Western University and a Bachelor of Science Honours in Life Sciences/Immunology from Queen's University.